The invention relates to calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-[ [(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate, to processes for its preparation, and to its use in the treatment of diseases caused by retroviruses.